Vickers Seals the Deal with Scilex, More Mining This Week with MTAL

by | Mar 17, 2022

Vickers announces long-awaited merger with Scilex. More mining action this week. Moelis & Co. bowing out of 2 SPAC IPOs. And all the day’s news in SPACs.

Free Investor Resources from Boardroom Alpha
** Podcast: Know Who Drives Return
** Daily SPAC Newsletter
** Full SPAC Listing

VCKA and Scilex seal the deal

Vickers Vantage Corp. I (VCKA) and Scilex Holding Company announce their merger. Scilex focuses on non-opioid therapies for patients with acute and chronic pain, and is a majority-owned subsidiary of Sorrento Therapeutics (SRNE). Scilex shareholders will own approximately 88% of the new company. The merger is expected to close by 3Q 2022; Scilex will trade under the new ticker symbol “SCLX.” No mention of additional financing in the press release other than its $140M trust.

MTAL to acquire CSA Copper Mine from Glencore for $1.1B

Mining is hot this week. On the heels of AMC’c investment in Hycroft Mining Corp. (HYMC), we have another mining deal, this time in SPACland. SPAC Metals Acquisition Corp. (MTAL) announced the acquisition of CSA Copper Mine (New South Wales, Australia) from Glencore plc (LSE: GLEN) for $1.05 billion in cash and $50 million in stock. Also included in the consideration for the acquisition is a 1.5% copper net smelter royalty to Glencore. The purchase price implies a 4.5x multiple of 2022E EBITDA. Financing is complicated (senior debt, convert, PIPE); see the presentation here. MTAL stock traded up today, closing at $9.66. Unlike AMC’s baffling announcement earlier this week, CSA looks very much within MTAL’s wheelhouse. It’s also one of Australia’s highest grade copper mines. Good timing for buying a copper mine, particularly given a very evident Electric Vehicle (EV) production ramp.


Source: Company presentation

FRSG and EO Charging cancel merger plans

Another SPAC merger bites the dust. First Reserve Sustainable Growth Corp.(FRSG) and EV fleet charging provider EO Charging terminated their merger agreement, citing “unfavorable market conditions.

Moelis getting out of the SPAC game?

Moelis & Company withdrew 2 SPAC IPO S-1s its Atlas 3, 4. The SPACs had filed for their IPOs in March last year and were looking to raise over $1 billion. However, at the same time, they filed an S-1/A and rebranded what was Atlas Crest V to Atlas Crest III, a proposed $200M IPO.

Atlas Crest II (ACII) is still searching for a merger target. Meanwhile, shares of aircraft manufacturing company Archer Aviation (ACHR), which deSPAC’d from Atlas Crest I, are struggling at ~$4. That deal got done only after cutting the valuation by $1 billion.

Elsewhere in SPACs

  • Pan European electric vehicle (EV) charging infrastructure provider Allego (ALLG) deSPAC’d today. Shares closed at $9.20.
  • Asia online property portal Property Guru (PRGU) deSPACs tomorrow.

SPAC Calendar

SPAC Deal Votes

  • Mar 22 | TWNT –> TERRAN ORBITAL Corp
  • Mar 29 | HTPA –> Packable
  • Mar 31 | HLXA –> MoonLake Immunotherapeutics AG

SPAC Extension Votes

  • Mar 18 | VHAQ
  • Mar 18 | AMAO
  • Mar 22 | THCA

More from Boardroom Alpha

For ongoing tracking, analytics, and data on SPACs checkout Boardroom Alpha’s SPAC Data and Analytics service.

<a href="" target="_self">Joanna Makris</a>

Joanna Makris

Joanna has been analyzing and investing in emerging technologies for over two decades, having led the Technology, Media, and Telecom research at several global investment banks, including Mizuho Securities and Canaccord Genuity. Navigating stock market volatility since it all began in 2000. Banjo player, artist, and frittata-maker.

Know Who Drives Return

Objective, data-driven assessments for every public company director and officer.

SPAC Analytics & Database

Comprehensive research and analytics on every SPAC, sponsor, and deal. Real-time alerts, yields, red flags, filings, investors, and much more. API access to institutional grade SPAC database.

Monthly SPAC Review

SPAC Market Review – April 2022

The market is a mess right now. A hawkish Fed and even more cautious SEC are slowing deals….but may raise the bar for more quality SPACs down the line.

SPAC Market Review – March 2022

Despite increased scrutiny and apparent investor fatigue, deals are getting done and SPACs remain an attractive path to the public markets.

SPAC Research & Analysis

Starting the Week with 2 DAs

Starting the week off with 2 DAs– oil & gas and battery tech. And the rest of the day’s news in SPACs.

Comera Gets Approval, with Over 98% Redemptions

Squeeze alert: OTRA approves its merger with Comera Life Sciences, albeit with some of highest redemptions we’ve seen in a while (98.4%). And the rest of the day’s news in SPACs.

Know Who Drives Return Podcast

NYC Pension Funds Want Amazon Accountable for Human Capital

AMZN stock is performing, but are warehouse workers paying the price? We talk to Assistant NYC Comptroller Michael Garland on the NYC Pension Funds’ move to unseat two Amazon board members responsible for human capital management at the tech giant.

Boardroom Alpha Daily Read

Board blow-up at Redbox Entertainment. Mill Road Capital Pushing for a Sale of Big Lots. Happy Earth Day! A perfect time to tune into our latest ESG podcast.


The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.